Transcriptional addiction in mixed lineage leukemia: new avenues for target therapies

Mixed lineage leukemia (MLL) is an aggressive and refractory blood cancer that predominantly occurs in pediatric patients and is often associated with poor prognosis and dismal outcomes. Thus far, no effective target therapy for the treatment of MLL leukemia is available. MLL leukemia is caused by t...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Ruijing, Wang, Honghong, Liang, Kaiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975088/
https://www.ncbi.nlm.nih.gov/pubmed/35402805
http://dx.doi.org/10.1097/BS9.0000000000000011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975088/
https://www.ncbi.nlm.nih.gov/pubmed/35402805
http://dx.doi.org/10.1097/BS9.0000000000000011

Ejemplares similares